BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. May 27, 2026; 18(5): 115921
Published online May 27, 2026. doi: 10.4240/wjgs.v18.i5.115921
Table 1 Comparison of baseline data between two groups, n (%)
Item
Study group (n = 60)
Control group (n = 60)
t/χ2
P value
Age (years, mean ± SD)58.4 ± 12.360.1 ± 11.7-0.7860.434
Gender0.2670.605
    Male36 (60.0)39 (65.0)
    Female24 (40.0)21 (35.0)
BMI (kg/m², mean ± SD)22.1 ± 3.421.8 ± 3.20.5120.610
Gastric cancer pathological type1.4290.699
    Adenocarcinoma48 (80.0)51 (85.0)
    Signet ring cell carcinoma8 (13.3)6 (10.0)
    Others4 (6.7)3 (5.0)
Surgical method0.6980.705
    Total gastrectomy15 (25.0)18 (30.0)
    Distal subtotal gastrectomy32 (53.3)29 (48.3)
    Proximal subtotal gastrectomy13 (21.7)13 (21.7)
Postoperative time (months, mean ± SD)3.2 ± 1.83.5 ± 2.1-0.8460.399
Past medical history
    Hypertension18 (30.0)22 (36.7)0.6160.433
    Diabetes8 (13.3)11 (18.3)0.5710.450
    Coronary heart disease5 (8.3)7 (11.7)0.3800.537
    Comorbid conditions
    Gastroesophageal reflux disease12 (20.0)15 (25.0)0.4370.509
Chronic gastritis8 (13.3)10 (16.7)0.2670.605
    Irritable bowel syndrome4 (6.7)6 (10.0)0.4340.510
Preoperative gastroscopy results0.8470.838
    Gastric antrum lesions28 (46.7)31 (51.7)
    Gastric body lesions18 (30.0)16 (26.7)
    Gastric fundus lesions9 (15.0)8 (13.3)
    Diffuse lesions5 (8.3)5 (8.3)
Table 2 Comparison of Nepean Dyspepsia Index score changes between two groups (mean ± SD, points)
Group
Cases
Before treatment
After 4 weeks treatment
4 weeks follow-up
Study group6072.4 ± 8.938.2 ± 12.1a43.8 ± 13.2
Control group6073.1 ± 9.252.7 ± 14.356.2 ± 15.6
F valueBetween-group effect: 28.45Time effect: 89.67Interaction effect: 6.38
P value< 0.001< 0.0010.003
Table 3 Comparison of Gastrointestinal Symptom Rating Scale score changes between two groups (mean ± SD, points)
Group
Cases
Before treatment
After 2 weeks
After 4 weeks
4 weeks follow-up
Study group6058.3 ± 11.243.8 ± 10.229.7 ± 8.4a34.5 ± 10.1
Control group6059.1 ± 10.846.5 ± 10.436.8 ± 10.340.2 ± 11.8
F valueBetween-group effect: 24.86Time effect: 112.45Interaction effect: 8.32
P value< 0.001< 0.001< 0.001
Table 4 Comparison of serum motilin and gastrin level changes between two groups (mean ± SD)
GroupCasesMLT (pg/mL)
GAS (ng/L)
Before treatment
After 4 weeks
Before treatment
After 4 weeks
Study group6086.3 ± 15.2108.7 ± 16.8a78.4 ± 12.668.5 ± 11.2a
Control group6087.1 ± 14.896.8 ± 15.379.2 ± 13.175.6 ± 12.4
t value-0.2914.126-0.337-2.187
P value0.772< 0.0010.7370.031
Table 5 Comparison of Traditional Chinese medicine symptom scale score changes between two groups (mean ± SD, points)
Group
Cases
Before treatment
After 2 weeks
After 4 weeks
4 weeks follow-up
Study group6013.2 ± 2.89.2 ± 2.65.8 ± 2.1a6.8 ± 2.5
Control group6013.5 ± 2.610.7 ± 2.87.6 ± 2.48.3 ± 2.7
F valueBetween-group effect: 35.67Time effect: 156.32Interaction effect: 11.24
P value< 0.001< 0.001< 0.001


Write to the Help Desk